Today, Raycision’s independently developed IMAGING 200pro 3D In Vivo Optical Molecular Imaging System was officially packed and shipped to a laboratory at a leading university medical school in the Netherlands.
This milestone marks the entry of Raycision’s core optical molecular imaging technology into the European advanced research market, reflecting growing recognition and adoption of the company’s technology by international researchers.
Optical molecular imaging plays an important role in preclinical research. However, conventional 2D imaging is limited by the lack of depth information, signal overlap, and difficulties in accurately localizing signals. The IMAGING 200pro was developed to address these challenges by enabling the detection of deep-tissue signals and more precise three-dimensional spatial localization.
The IMAGING 200pro employs multi-angle structured-light technology to reconstruct the three-dimensional surface of small animals. Combined with high-precision 3D optical reconstruction algorithms, the system enables depth-resolved analysis and three-dimensional localization of optical signals.
The system also incorporates an AI model trained on real-world data to predict the positions of multiple organs. This allows fluorescent signals to be mapped directly to specific organs, significantly improving the accuracy and research value of in vivo analysis.
Equipped with an ultra-high-pixel scientific-grade cooled CCD camera, the IMAGING 200pro delivers extremely low noise and high sensitivity, enabling the detection of weak bioluminescent and fluorescent signals. It maintains excellent image quality while supporting rapid image acquisition.
Multi-angle image acquisition further improves data completeness, providing a reliable foundation for subsequent three-dimensional quantitative analysis.
Powered by advanced reconstruction algorithms and intelligent analysis capabilities, the IMAGING 200pro generates clearer and more information-rich 3D images while providing key quantitative parameters such as depth, volume, and size.
With submillimeter localization accuracy, the system provides high-quality imaging support for a wide range of preclinical applications, including tumor volume assessment, drug screening, and metabolic research.
The successful shipment of the IMAGING 200pro to the Netherlands represents an important step forward in Raycision’s global expansion.
Looking ahead, Raycision will continue to advance optical imaging technologies and bring more innovative scientific instruments developed in China to researchers around the world.
